SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,926.81 67.82
( 0.09%)

Global Indices

Nasdaq

52,073.35 369.71
(0.72%)

Dow Jones

7,785.28 113.78
(1.48%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,737.46 78.33
(0.73%)

Forex

USD-INR

95.87 0.21
(0.22%)

EUR-INR

110.00 -0.22
(-0.20%)

GBP-INR

128.18 -0.44
(-0.35%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Amrutanjan Health Care Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

590006

INE098F01031

128.0610499

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AMRUTANJAN

23.02

1432.38

EPS(TTM)

Face Value()

Div & Yield %

21.52

0.99

Back

Nalwa Sons Investments consolidated net profit rises 3.37% in the June 2026 quarter

Aug 08,2026

Net profit of Nalwa Sons Investments rose 3.37% to Rs 26.66 crore in the quarter ended June 2026 as against Rs 25.79 crore during the previous quarter ended June 2025. Sales declined 7.31% to Rs 34.38 crore in the quarter ended June 2026 as against Rs 37.09 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	34.38	37.09	-7
OPM %	98.28	88.33	-
PBDT	33.85	32.79	3
PBT	33.85	32.78	3
NP	26.66	25.79	3

74,926.81 67.82 ( 0.09%)

52,073.35 369.71 (0.72%)

7,785.28 113.78 (1.48%)

65,040.24 903.99 (1.41%)

10,737.46 78.33 (0.73%)

95.87 0.21 (0.22%)

110.00 -0.22 (-0.20%)

128.18 -0.44 (-0.35%)

0.61 0.00 (-0.09%)